4 results match your criteria: "USA. achatterjee1@tuftsmedicalcenter.org.[Affiliation]"
Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients.
Ann Surg Oncol
October 2022
Division of Surgical Oncology, Tufts Medical Center, Boston, MA, USA.
Background: There have been conflicting studies reporting on survival advantages between breast-conserving surgery with radiotherapy (BCS) in comparison with mastectomy. Our aim was to compare the efficacy of BCS and mastectomy in terms of overall survival (OS) comparing all past published studies.
Methods: We performed a comprehensive review of literature through October 2021 in PubMed, Scopus, and EMBASE.
Editorial on Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis.
Ann Surg Oncol
January 2022
Tufts Medical Center, Boston, USA.
Editorial on "Neoadjuvant Chemotherapy Does Not Increase Complications in Oncoplastic Breast-Conserving Surgery".
Ann Surg Oncol
September 2019
Tufts Medical Center, Boston, MA, USA.
Trending Towards Safer Breast Cancer Surgeries? Examining Acute Complication Rates from A 13-Year NSQIP Analysis.
Cancers (Basel)
February 2019
Department of Surgery, Tufts Medical Center, 800 Washington Street, South Building, 4th Floor, Boston, MA 02111, USA.
As breast cancer surgery continues to evolve, this study highlights the acute complication rates and predisposing risks following partial mastectomy (PM), mastectomy(M), mastectomy with muscular flap reconstruction (M + MF), mastectomy with implant reconstruction (M + I), and oncoplastic surgery (OPS). Data was collected from the American College of Surgeons NSQIP database (2005⁻2017). Complication rate and trend analyses were performed along with an assessment of odds ratios for predisposing risk factors using adjusted linear regression.
View Article and Find Full Text PDF